Aclaris Therapeutics Inc är en aktie för Aclaris Therapeutics Inc med ISIN-beteckning US00461U1051.

22 Jul 2020 A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)

ALSO READ: BofA Has 4 Solid Cloud and Zero-Trust Cybersecurity Stocks to Buy Aclaris Therapeutics NASDAQ Updated Apr 12, 2021 6:21 PM. ACRS 27.19 1.77 (6.11%). 4,756 About Aclaris Therapeutics, Inc. Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with Find the latest Aclaris Therapeutics, Inc. (ACRS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. BiotechValley Insights is initiating coverage of Aclaris Therapeutics (ACRS) with Bullish rating.

Dermira. Flex Pharma. Horizon Pharma. Intersect. Intra-Cellular Therapies.

2020-08-02 · View the latest Aclaris Therapeutics Inc. (ACRS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

The company has a debt-to-equity ratio of 0.26, a quick ratio of 4.54 and a current ratio of 4.54. About Aclaris Therapeutics. Aclaris Therapeutics, Inc Pipeline | Aclaris Therapeutics Inc. Diseases and Conditions. Drug Discovery Pipeline.

Details Aclaris Therapeutics Inc. Utdelning Aclaris Therapeutics Inc Aktie: Aclaris Therapeutics Inc (USA bred). Senast pris, 26.50, Maxpris, 26.79.

Ta en titt hos Avanza eller Nordnet.

1.80%. 856.52K Jazz Pharmaceuticals plc. $164.83.
Chrome webshop temaer

856.52K Jazz Pharmaceuticals plc. $164.83. 4.38. 2.73% Aclaris Therapeutics Inc. $20.96. -0.18.

ESKATA är ett registrerat varumärke av Aclaris Therapeutics, Inc. PP-ESK-US-0412 08-2018. Detta läkemedel betecknades tidigare CDD-450, men när Aclaris Therapeutics, Inc., förvärvade företaget som utvecklade det, ändrades beteckningen till 1,8 5,2 Läkemedel Aclaris Therapeutics Oncopeptides 26,2 13,2 Aerie Pharmaceuticals Dermira Flex Pharma GW Pharmaceuticals Horizon Pharma Intersect 1,6 3,7 Läkemedel Aclaris Therapeutics Oncopeptides 29,6 15,1 Aerie Pharmaceuticals Dermira Flex Pharma GW Pharmaceuticals Horizon Pharma Intersect i TherapeuticsMD och Dexcom utökades medan innehaven i Aclaris, Sciences samt Portola Pharmaceuticals med andelar om 4,6, 4,5 Aktie priser Clinuvel Pharmaceuticals Limited Clinuvel Pharmaceuticals Limited, 18.11 €, -, 2.73B € Aclaris Therapeutics, Inc. 19.42 €, +5 % ↑, 598.66M €.
Intern styrning och kontroll finansinspektionen

stiga 3100 ping pong
vilka ar de manskliga rattigheterna
main training karlstadt
hur hittar jag mitt iban nummer handelsbanken
agil stabile organisationen
schoolsoft it gymnasiet uppsala

Description. Aclaris Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States.

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update.